Back
Monopar Therapeutics Quote, Financials, Valuation and Earnings
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
75
MNPR
Monopar Therapeutics
Last Price:
30.75
Seasonality Move:
35.55%
7 Day Trial
ALL ACCESS PASS
$
7
This is an offer you won't want to refuse...
Hurry. Don't miss these two trades.Monopar Therapeutics Price Quote
$30.75
+0.07 (+0.23%)
(Updated: December 18, 2024 at 9:35 AM ET)
Monopar Therapeutics Key Stats
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Day range:
$26.00 - $31.96
52-week range:
$1.55 - $38.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
32.73%
Volume:
109.4K
Avg. volume:
113.3K
1-year change:
1564.23%
Market cap:
$161.9M
Revenue:
$0
EPS:
$-1.99
How Much Does Monopar Therapeutics Make?
Data Unavailable
Is Monopar Therapeutics Growing As A Company?
Data Unavailable
Monopar Therapeutics Stock Price Performance
-
Did Monopar Therapeutics Stock Go Up Last Month?
Monopar Therapeutics share price went up by 69.6% last month -
Did MNPR's Share Price Rise Over The Last Year?
MNPR share price rose by 1564.23% over the past 1 year
What Is Monopar Therapeutics 52-Week High & Low?
-
What Is Monopar Therapeutics’s 52-Week High Share Price?
Monopar Therapeutics has traded as high as $38.50 over the past 52 weeks -
What Is Monopar Therapeutics’s 52-Week Low Share Price?
Monopar Therapeutics has traded as low as $1.55 over the past 52 weeks
Monopar Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Monopar Therapeutics?
-
How Much Debt Does Monopar Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Monopar Therapeutics Have?
Cash and short term investments quarterly total is $6M -
What Is Monopar Therapeutics’s Book Value Per Share?
Book value per share is 1.40
Is Monopar Therapeutics Cash Flow Positive?
-
What Is MNPR Cash Flow From Operations?
Cash flow from operations (TTM) is -$6M -
What Is Monopar Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.5M -
What Is Monopar Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $3M
Monopar Therapeutics Return On Invested Capital
Data Unavailable
Monopar Therapeutics Earnings Date & Stock Price
-
What Is Monopar Therapeutics's Stock Price Today?
A single share of MNPR can be purchased today for 30.68 -
What Is Monopar Therapeutics’s Stock Symbol?
Monopar Therapeutics trades on the nasdaq under the ticker symbol: MNPR -
When Is Monopar Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Monopar Therapeutics is scheduled on March 28, 2025 -
When Is MNPR's next ex-dividend date?
Monopar Therapeutics's next ex-dividend date is December 18, 2024 -
How To Buy Monopar Therapeutics Stock?
You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Monopar Therapeutics Competitors
-
Who Are Monopar Therapeutics's Competitors?
Below is a list of companies who compete with Monopar Therapeutics or are related in some way:
Monopar Therapeutics Dividend Yield
-
What Is MNPR Dividend Yield?
Monopar Therapeutics’s dividend yield currently is 0% -
What Is Monopar Therapeutics’s Payout Ratio?
Monopar Therapeutics’s payout ratio is 0% -
When Did Monopar Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 18, 2024 -
What Is Monopar Therapeutics’s Dividend Per Share?
Monopar Therapeutics pays a dividend of $0.00 per share
Monopar Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -58.12% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 27.33 |
| Downside from Last Price: | -10.91% |